Medicare Enrolled
Dr. Edward Jamelarin
Hematology & Oncology · Columbus, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jamelarin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jamelarin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jamelarin
Dr. Edward Jamelarin is a hematology & oncology specialist in Columbus, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jamelarin performed 1,532 Medicare services across 915 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jamelarin received a total of $10,461 from 73 pharmaceutical and/or device companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jamelarin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in OH
$10,461 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,532
Medicare services
Top 22% in OH for hematology & oncology
915
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
847 | $86 | $184 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
467 | $131 | $257 |
| New patient office visit, complex (60-74 min) | 71 | $158 | $331 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
39 | $8 | $13 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $119 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $66 | $129 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $94 | $222 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,461
Total received (2018-2024)
Avg $1,494/year across 7 years
Top 28% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
559
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,280 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$182 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,428
2023
$2,574
2022
$2,270
2021
$520
2020
$238
2019
$1,317
2018
$1,114
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$328
AstraZeneca Pharmaceuticals LP
$201
ABBVIE INC.
$178
Merck Sharp & Dohme LLC
$140
Eisai Inc.
$118
Incyte Corporation
$114
Janssen Biotech, Inc.
$93
Novartis Pharmaceuticals Corporation
$90
Astellas Pharma US Inc
$81
E.R. Squibb & Sons, L.L.C.
$77
Regeneron Healthcare Solutions, Inc.
$74
Daiichi Sankyo Inc.
$73
Genentech USA, Inc.
$70
ADC Therapeutics America, Inc.
$68
GENZYME CORPORATION
$63
SOBI, INC
$56
Stemline Therapeutics Inc.
$54
Ipsen Biopharmaceuticals, Inc
$53
Alexion Pharmaceuticals, Inc.
$52
ARRAY BIOPHARMA INC
$47
Gilead Sciences, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Karyopharm Therapeutics Inc.
$41
Blueprint Medicines Corporation
$41
Celgene Corporation
$39
Lilly USA, LLC
$35
TerSera Therapeutics LLC
$29
PROGENICS PHARMACEUTICALS, INC.
$20
GlaxoSmithKline, LLC.
$17
BeiGene USA, Inc.
$17
Mirati Therapeutics, Inc.
$17
Rigel Pharmaceuticals, Inc.
$16
Menarini Silicon Biosystems, Inc.
$15
Myriad Genetic Laboratories, Inc.
$13
Exact Sciences Corporation
$8
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$923
Janssen Biotech, Inc.
$633
Genentech USA, Inc.
$592
AstraZeneca Pharmaceuticals LP
$570
E.R. Squibb & Sons, L.L.C.
$469
Novartis Pharmaceuticals Corporation
$450
Seagen Inc.
$389
GENZYME CORPORATION
$351
Celgene Corporation
$326
Incyte Corporation
$310
Daiichi Sankyo Inc.
$291
Merck Sharp & Dohme LLC
$286
Regeneron Healthcare Solutions, Inc.
$250
Takeda Pharmaceuticals U.S.A., Inc.
$248
Astellas Pharma US Inc
$242
Eisai Inc.
$229
Merck Sharp & Dohme Corporation
$227
Lilly USA, LLC
$224
ABBVIE INC.
$212
Pharmacyclics LLC, An AbbVie Company
$188
Gilead Sciences, Inc.
$174
Amgen Inc.
$152
ADC Therapeutics America, Inc.
$148
Ipsen Biopharmaceuticals, Inc
$140
Karyopharm Therapeutics Inc.
$139
Exelixis Inc.
$127
ARRAY BIOPHARMA INC
$126
TESARO, Inc.
$122
EMD Serono, Inc.
$115
Alexion Pharmaceuticals, Inc.
$111
Rigel Pharmaceuticals, Inc.
$109
Myriad Genetic Laboratories, Inc.
$86
TerSera Therapeutics LLC
$80
Acrotech Biopharma LLC
$77
SOBI, INC
$73
Sumitomo Pharma America, Inc.
$67
GlaxoSmithKline, LLC.
$66
Pharmacyclics LLC, an AbbVie Company
$61
Bayer HealthCare Pharmaceuticals Inc.
$60
CTI BioPharma Corp.
$57
Stemline Therapeutics Inc.
$54
AVEO Pharmaceuticals, Inc.
$52
EISAI INC.
$51
Myovant Sciences Inc.
$51
Coherus Biosciences Inc.
$50
Teva Pharmaceuticals USA, Inc.
$49
Sobi, Inc
$49
PUMA BIOTECHNOLOGY, INC.
$49
Sun Pharmaceutical Industries Inc.
$48
Taiho Oncology, Inc.
$47
Blueprint Medicines Corporation
$41
GE HealthCare
$40
Puma Biotechnology, Inc.
$37
G1 Therapeutics, Inc.
$35
Mirati Therapeutics, Inc.
$34
MorphoSys, US Inc.
$31
JAZZ PHARMACEUTICALS INC.
$21
PROGENICS PHARMACEUTICALS, INC.
$20
BeiGene USA, Inc.
$17
AbbVie Inc.
$17
Genmab U.S., Inc.
$16
Menarini Silicon Biosystems, Inc.
$15
AbbVie, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Fortovia Therapeutics, Inc.
$13
Epizyme, Inc.,
$13
Advanced Accelerator Applications
$13
Kite Pharma, Inc.
$12
Dova Pharmaceuticals
$12
Verastem, Inc.
$12
INSYS Therapeutics Inc
$11
Tactile Systems Technology Inc
$11
Exact Sciences Corporation
$8
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALOXI · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · BAVENCIO · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Cologuard Collection Kit · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FLEXITOUCH · FOTIVDA · FRUZAQLA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Nplate · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PRECISETUMOR · PROMACTA · PYLARIFY · Padcev · Perjeta · Phesgo · Pomalyst · PreciseTumor · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vonjo · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · ZEJULA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
54
Per 100K population
4.1
County median income
$73,795
Nearest hospital
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jamelarin is a clinical cardiology specialist, with above-average Medicare volume (top 22% in OH), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jamelarin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Jamelarin performed 847 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jamelarin receive payments from pharmaceutical companies?
Yes. Dr. Jamelarin received a total of $10,461 from 73 companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jamelarin's costs compare to other hematology & oncology specialists in Columbus?
Dr. Jamelarin's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jamelarin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Columbus
Browse hematology & oncology specialists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology